Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2266

Actual shortage: 50 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 19 (1%)
Resolved: 2197 (97%)

Discontinuation Reports

124

To be discontinued: 4 (3%)
Discontinued: 118 (95%)
Reversed: 2 (2%)

Late reports

451 (19%)

Overdue reports

11 (20%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2017-10-27 2017-11-19 27239
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2018-11-26 2018-12-05 67605
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2018-12-20 2019-02-04 70256
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2019-03-05 2019-06-28 77737
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2021-12-02 2021-12-30 150323
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2022-02-02 2022-03-11 154106
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2022-03-14 2022-04-20 156669
LABETALOL HYDROCHLORIDE INJECTION USP 5MG LIQUID Resolved 2022-06-09 2022-10-20 162363
LABETALOL HYDROCHLORIDE INJECTION USP 5MG SOLUTION LIQUID Resolved 2025-01-13 2025-02-11 247608
LABETALOL HYDROCHLORIDE INJECTION USP 5MG SOLUTION LIQUID Resolved 2025-03-03 2025-04-01 251573
LABETALOL HYDROCHLORIDE INJECTION USP 5MG SOLUTION LIQUID Resolved 2025-06-02 2025-07-01 259061
LORAZEPAM INJECTION USP 4MG SOLUTION LIQUID Resolved 2021-12-20 2021-12-30 151603
LORAZEPAM INJECTION USP 4MG SOLUTION LIQUID Resolved 2022-01-12 2022-01-18 152589
LORAZEPAM INJECTION USP 4MG SOLUTION LIQUID Resolved 2022-03-14 2023-07-28 156638
LOXAPAC IM 50MG LIQUID Resolved 2021-01-18 2021-02-01 131830
LOXAPAC IM 50MG LIQUID Resolved 2022-11-28 2022-12-11 175993
LOXAPAC IM 50MG LIQUID Resolved 2023-03-20 2023-04-05 187444
LOXAPAC IM 50MG SOLUTION LIQUID Resolved 2024-04-30 2024-11-14 226623
LOXAPAC IM 50MG SOLUTION LIQUID Resolved 2024-09-03 2024-09-17 236567
MAGNESIUM SULFATE INJECTION USP 200MG LIQUID Resolved 2023-01-20 2023-02-16 181990

Showing 321 to 340 of 2266

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 124